All participants underwent physical examinations on the first day of the study. Height, body weight, systolic blood pressure, and diastolic blood pressure were recorded. The blood pressure of each patient was measured after 10 min of rest via the right arm in the seated position using an Omron
IntelliSense Automatic Blood Pressure Monitor (Omron, Kyoto, Japan). The height and body weight were measured without shoes in the morning. The BMI was calculated as weight in kg divided by height in m
2. All blood samples were collected into tubes containing EDTA in the morning, after an overnight fast of more than 8 h. We measured the levels of fasting glucose, TG, (TC), LDL-C, HDL-C, aspartate aminotransferase, alanine aminotransferase, and thyroid stimulating hormone (TSH). Blood chemistry and lipid profiles were assessed using a blood chemistry analyzer (747; Hitachi, Tokyo, Japan).
Kang Y.E., Kim J.T., Lim M.A., Oh C., Liu L., Jung S.N., Won H.R., Lee K., Chang J.W., Yi H.S., Kim H.J., Ku B.J., Shong M, & Koo B.S. (2019). Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer. Cancers, 11(8), 1154.